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Initiatives to improve epilepsy care have emphasized the role of specialist nurses. Formal evaluation of these initiatives are
scarce. Further evaluative studies are required to ascertain the optimal means of providing epilepsy care. This study aimed to
assess the effect of a primary-care-based epilepsy specialist nurse service on patients’ reported health status, perceived quality
of life, health care use, attitudes to health care, and provision of information. A quasi-experimental follow-up questionnaire
survey was sent to all 574 patients aged 16 years or over and receiving antiepileptic drugs for epilepsy, registered in 14 general
practices in north-west Bristol. Patients in seven practices who received the new service (intervention patients) were compared
with patients in seven practices who did not (control patients). Follow-up comparisons between intervention and control patients
were adjusted for baseline differences. Response rates to the first, second and both surveys were 66.2%, 68.6% and 50.9%,
respectively. Intervention patients were more likely than control patients to have discussed most epilepsy topics with general
practitioners and/or hospital doctors, and were significantly more likely to have categorized general practitioner care as excellent
(odds ratio (OR) 2.30, 95% confidence intervals (CI) 1.12–4.70). Intervention patients were significantly less likely than controls
to have reported never missing taking their anti-epileptic drugs (OR 0.48, 95% CI 0.24–0.94). There were no significant changes
in measures of health status, use of other health care services, and perceived quality of life between intervention and control
patients. This study provides evidence of an improvement, after 1 year, in communication and satisfaction but not health status
resulting from the introduction of a primary-care-based epilepsy service.
Key words: epilepsy; specialist nurse; quality of health care; health services research; patients’ perspective; primary/secondary
care interface.Introduction
Problems with epilepsy care and the need for improve-
ments have been well documented, highlighting the
need for structured, regular care1–3. Initiatives to im-
prove care have particularly focused on extending spe-
cialist care into primary care, with emphasis on the role
of specialist nurses4, 5.
Formal evaluations of these initiatives are needed to
ascertain the optimal means of providing epilepsy care.
There is only one published randomized controlled
trial on the effect of general-practice-based nurse-run
epilepsy clinics, but this includes a limited range of
short-term process measures5. Qualitative interviews
with a sub-sample of patients from this trial suggest
greater satisfaction with care from the epilepsy nurse‡E-mail: nicola.mills@bris.ac.uk
1059–1311/99/010001 + 07 $12.00/0than from the doctors6. However, further evaluative
studies are required.
In 1995 the district health authority funded the
employment of a part-time general-practice-based
epilepsy specialist nurse in one locality in Bristol,
United Kingdom. This paper reports on a controlled
study which aimed to assess the effects of the new nurse
service on patients’ reported health status, perceived
quality of life, use of and attitudes to health care, and
provision of information.
Materials and methods
The study was of a quasi-experimental, controlled
before-and-after design. Fourteen general practices in
north-west Bristol were allocated into intervention or
control groups with similar distributions of practicec© 1999 British Epilepsy Association
2 N. Mills et al.size, doctor:population ratio, socio-economic status,
and mean distance from hospital. Baseline data on pa-
tients with epilepsy were collected prior to the intro-
duction of the new service3.
A part-time (67% full-time employment) Grade H
epilepsy specialist nurse was based in one practice and
worked with patients and staff in seven (intervention)
practices. Her role was to provide information, ad-
vice and support to patients, liaise between different
components of the health service and the wider pub-
lic sector, and educate primary-health-care teams. Two
hundred and eighty three patients were invited by let-
ter to arrange an appointment with the epilepsy nurse,
of whom 128 (45%) attended. The mean number of
consultations per patient was one and mean consulta-
tion length was 45 minutes. Eighty percent of consul-
tations were conducted in the patients’ general prac-
tice, the remainder were home visits. The consultation
involved a nursing assessment to obtain the patient’s
history and identify needs. Where appropriate, clini-
cal examinations were performed, advice, information
and support provided, and referrals and recommenda-
tions for care made. Progress notes summarizing the
consultation were added to patients’ medical records.
Staff from intervention practices were invited to attend
epilepsy study days organized by the epilepsy nurse.
The epilepsy nurse regularly attended neurology out-
patient clinics, relevant courses and conferences for
self-education.
The study population comprised 574 (278 interven-
tion and 296 control) subjects with epilepsy, defined as
all patients aged 16 years or over and currently on med-
ication for epilepsy. No patients were excluded. Where
patients were unable to complete questionnaires carers
were asked to fill in the form on their behalf. If com-
plete information was obtained from 200 patients in
each arm of the study, the sample size would be suf-
ficient, with 80% power and 5% significance level, to
detect a difference between trial arms of 14% (40%
vs. 26%) in patients having had attacks in the previous
year.
Self-completion questionnaires were posted to all pa-
tients at baseline, then 1 year later. The questionnaires
were originally based upon the Living with Epilepsy
survey instrument developed and validated by Jacoby
and colleagues7, and used previously in other British
studies3, 8, 9. The primary outcome measures were: fre-
quency of epilepsy attacks, numbers using more than
one antiepileptic drug, provision of information, and
use of and attitudes to care. The secondary outcome
measures were: preferences of primary- or secondary-
based care, and the perceived effect of epilepsy and
its treatment on everyday life. In the follow-up ques-
tionnaire additional information was sought about the
use of and attitudes towards the epilepsy specialist
nurse.Questionnaires were accompanied by covering let-
ters from the patients’ general practitioners informing
them of the purpose of the study. Non-responders were
followed up three times. For the final follow-up short-
ened versions of the questionnaire, which included the
primary outcome measures, were sent by recorded de-
livery.
Data were analysed on SAS (version 6.12 SAS Insti-
tute Inc., Cary, NC, USA). The primary analysis com-
pared intervention with control patients. Secondary
analysis compared intervention patients who accepted
the invitation to see the epilepsy specialist nurse with
intervention patients who did not. Perceived quality of
life was assessed primarily from ten questions about
the effects of epilepsy and its treatment on daily liv-
ing; each had a four-point response scale (1 D a lot,
4 D not at all). For analysis, categories were collapsed
into binary outcomes; a lot, some, a little effect vs.
not at all affected. Baseline differences between inter-
vention and control patients, and between intervention
patients who saw the epilepsy nurse and those who
did not, were adjusted for in multiple logistic models
by including the baseline measure as an independent
variable. Age and gender were tested as potential con-
founders in all models and retained where confounding
occurred.
Results
Response rates were 66.2% (394/595) at baseline and
68.6% (394/574) at follow-up. The difference in de-
nominator is due to patients who had moved or died dur-
ing the period. Data at both time points were available
for 303/595 (50.9%) patients. Intervention and control
groups had similar response rates at baseline (199/288
(69.1%) and 195/307 (63.5%)), and similar follow-up
rates (148/199 (74.4%) and 155/195 (79.5%)). At base-
line, patients subsequently lost to follow-up were no
different regarding frequency of attacks or long-term
illness, but were significantly younger (47.1 vs. 53.4
(mean) years; P D 0:0029), compared to patients who
were followed-up.
The mean age of the 303 patients responding at both
time points was 53.8 years (standard deviation (SD)
16.6) and 54.5% (159/292) were male. Thirty-two per-
cent (82/260) were in full- or part-time employment and
51.3% (102/199) in manual social classes (IIIm–V).
Long-term health problems in addition to epilepsy were
reported by 48.1% (140/291) and 73.7% (216/293)
filled in the questionnaires themselves.
There were several differences in baseline character-
istics between control and intervention patients. Con-
trol patients were significantly more likely to have had
an epilepsy attack in the previous year, had experienced
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Table 1: Baseline characteristics of intervention and control patients.
Intervention Control
.n D 148/a .n D 155/a P
Age (mean (SD)) 53.3 (16.9) 53.6 (16.4) 0.90b
Sex (% male) 85 (58.6) 74 (48.4) 0.076c
In full/part-time employment (%) 44 (37.9) 42 (32.3) 0.36c
Manual social class (IIIm–V) (%) 47 (46.5) 59 (55.1) 0.22c
Other long-term health problems (%) 64 (44.4) 70 (46.4) 0.74c
Epilepsy attack in past year (%) 45 (32.4) 65 (45.8) 0.021c
Years free of epilepsy attacks (mean (SD)) 6.3 (9.5) 4.6 (6.8) 0.086b
Years of having had epilepsy attacks (mean (SD)) 15.2 (15.0) 21.4 (18.3) 0.0030b
Seen GP for any reason in past year (%) 84 (64.6) 101 (73.7) 0.12c
Seen GP for epilepsy in past year (%) 40 (41.7) 64 (57.1) 0.026c
Seen hospital doctor for epilepsy in past year (%) 25 (17.7) 42 (28.4) 0.032c
Feel unhappy about life as a whole (%) 58 (46.4) 71 (49.7) 0.60c
Feel stigmatized because of epilepsy (%) 38 (31.2) 42 (31.3) 0.97c
a Respondents to both baseline and follow-up surveys. Response rates to specific questions varied; denominators can be calculated using the
tabulated data. b t-test. c Chi-squared test (df. D 1).attacks for more years, and were more likely to have
seen a general practitioner or hospital doctor for their
epilepsy in the previous year (Table 1).
Use of epilepsy specialist nurse service
Of intervention patients, 48.3% (85/176) reported hav-
ing seen the epilepsy specialist nurse; 8.9% (18/203)
of control patients also reported contact. Of the 303
respondents to both questionnaires, 53.2% (75/141) of
intervention and 8.6% (13/151) of control patients re-
ported contact with the epilepsy nurse. Of patients who
had seen the epilepsy specialist nurse, general prac-
titioner or hospital doctor for epilepsy in the previ-
ous year the median numbers of consultations were 1
(range 1–3), 2 (range 1–12), and 2 (range 1–8), respec-
tively.
Among patients in the intervention group, baseline
factors predicting contact with the epilepsy specialist
nurse were investigated. Those who saw the epilepsy
nurse appeared to be more independent than those who
did not. They were significantly less likely to have
reported at baseline taking somebody with them for
help when visiting the hospital for their epilepsy (odds
ratio (OR) 0.08, 95% confidence intervals (CI) 0.00–
0.81), having someone else fill in the questionnaire on
their behalf (OR 0.19, 95% CI 0.07–0.49), having other
long-term health problems (OR 0.43, 95% CI 0.20–
0.90), and they were more likely, although not signif-
icantly so, to have reported holding a current driver’s
licence (OR 2.09, 95% CI 0.92–4.76). They were also
significantly more likely to have reported at baseline
preferring to receive all or most of their epilepsy care
from an epilepsy clinic in the general practice (OR
9.41, 95% CI 1.95–88.30), wanting discussion with the
general practitioner on aspects of epilepsy (OR 3.27,
95% CI 1.09–10.09) and they were more likely, al-
though not significantly so, to have reported missingtheir antiepileptic medication at some point (OR 2.63,
95% CI 0.98–7.17).
Epilepsy topics discussed
At follow-up, intervention patients were significantly
more likely than control patients to have discussed with
their general practitioner (or other practice staff ex-
cluding the epilepsy nurse) during the past year the
causes of their epilepsy, family life and epilepsy, so-
cial life or activities and epilepsy, and epilepsy self-
help groups, after controlling for baseline differences
(Table 2). They were also significantly more likely to
have discussed with a hospital doctor driving laws and
epilepsy, and epilepsy self-help groups (Table 2). Odds
ratios for having discussed most other topics with the
general practitioner or hospital doctor were greater than
one, but not significantly so.
Confining the analysis to intervention patients, those
who saw the epilepsy specialist nurse were significantly
more likely to have discussed ten out of 11 aspects of
epilepsy with their general practitioner or hospital doc-
tor, compared with those who did not see the nurse (Ta-
ble 3). Odds ratios for having discussed the effects of
epilepsy on family life and social life or activities, side
effects of epilepsy medication and interactions with
other drugs, with the general practitioner in particular,
were significantly greater than one (Table 3).
Use of and attitudes to health care
The new service did not reduce patients’ use of other
health care services (Table 2). Furthermore, interven-
tion patients who saw the epilepsy specialist nurse were
significantly more likely than those who did not to have
reported seeing the general practitioner for any reason
in the previous year (OR 2.45, 95% CI 1.01–5.92).
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Table 3: The likelihood of intervention patients discussing certain topics with the general practitioner and/or hospital doctor in the
previous year: those who saw the epilepsy specialist nurse compared with those who did nota.
Discussed with Discussed with Discussed with general practitioner
general practitioner hospital doctor or hospital doctor
ORb 95% CI ORb 95% CI ORb 95% CI
Causes of epilepsy 2.43 0.78–7.58 1.35 0.14–12.80 3.82 1.25–11.68
Types of epilepsy 2.92 0.91–9.31 −c −c 5.12 1.71–15.36
Side effects of antiepileptic drugs 3.43 1.12–10.55 3.77 0.58–24.69 3.95 1.44–10.82
Interactions of antiepileptic drugs
with other drugs 3.16 1.17–8.58 0.72 0.11–4.80 2.75 1.07–7.11
Alcohol and antiepileptic drugs 2.30 0.87–6.11 0.51 0.06–4.30 2.57 1.04–6.34
Contraception/pregnancy and
antiepileptic drugs 0.96 0.17–5.58 −c −c 0.88 0.16–4.97
Driving laws and epilepsy 2.83 0.92–8.67 1.30 0.07–25.92 2.96 1.04–8.44
Work study and epilepsy 3.20 0.96–10.61 3.20 0.25–40.41 3.93 1.30–11.85
Family life and epilepsy 7.69 1.89–31.29 −c −c 16.02 3.42–75.17
Social life/activities and epilepsy 4.14 1.21–14.19 −c −c 6.12 1.94–19.38
Epilepsy self-help groups 4.08 0.81–20.45 4.50 0.42–47.99 9.71 2.06–45.89
a Patients who replied to the same questions in the baseline and follow-up surveys.
b Adjusting for baseline value of outcome variable in multiple logistic regression model.
c Numbers too small for analysis.The intervention had no effect on changing patients’
perception of whether the general practitioner and/or
hospital doctor was their main provider of epilepsy
care. However, the service did have an effect on pa-
tients’ preferences for epilepsy care. Intervention pa-
tients who saw the epilepsy specialist nurse were sig-
nificantly less likely at follow-up to prefer receiving all
or most of their epilepsy care from the general prac-
titioner (OR 0.13, 95% CI 0.05–0.38), and were more
likely to not mind from whom they received their main
epilepsy care (OR 6.43, 95% CI 1.74–23.75), com-
pared with intervention patients who did not see the
nurse.
Of those who had seen their general practitioner in
the previous year, there was a significant higher proba-
bility of intervention compared with control patients re-
porting general practitioner care as excellent (OR 2.30,
95% CI 1.12–4.70), and, although not significantly so,
reporting the general practitioner as giving the right
amount of information (OR 2.01, 95% CI 0.92–4.37)
(Table 2). However, intervention patients were signifi-
cantly less likely than controls to have reported never
missing taking their antiepileptic drugs (OR 0.48, 95%
CI 0.24–0.94) (Table 2). Confining the analysis to inter-
vention patients, there were no significant differences
in the above outcome measures for patients who saw
the epilepsy nurse compared with those who did not.
Reported health status and perceived quality of
life
There were no statistically significant differences in
reported health status (Table 4) and perceived quality
of life between intervention and control patients. Con-fining the analysis to intervention patients and adjust-
ing for baseline differences, there were no significant
differences in reported health status between patients
who saw the epilepsy nurse and those who did not,
but there were differences in perceived quality of life.
Those who saw the epilepsy specialist nurse were sig-
nificantly more likely than those who did not to have re-
ported that epilepsy affected their future plans and am-
bitions (OR 6.19, 95% CI 2.07–18.50), overall health
(OR 4.28, 95% CI 1.77–10.34), and standard of living
(OR 2.74, 95% CI 1.05–7.16), to either a lot, some or
a little extent. Odds ratios for reporting an effect on
other areas of everyday life were greater than one, but
not significantly so. There were no significant interac-
tions between having seen the epilepsy nurse and time
since last epilepsy attack, on reported quality of life
variables.
Discussion
This study suggests that provision of an epilepsy spe-
cialist nurse for 1 year has improved communication
between patients and health professionals and levels
of patient satisfaction, but has not affected health sta-
tus and use of other health care services. By includ-
ing all eligible patients, whether or not they saw the
nurse (i.e. analysis by intention to treat), the estimated
effects on service users were diluted. However, this
provides a more valid reflection of the impact of a
population-based service with incomplete uptake, than
a trial including service users only. Given that most ser-
vice users only saw the nurse once, the effects seen are
substantial. Although patients were not randomized,
this is an advance on previous studies4, 5 in its inclu-
6 N. Mills et al.
Table 4: Changes in reported health statusa (% of patients).
Intervention .n D 148/b Control .n D 155/c
Baseline Follow-up Changes Baseline Follow-up Changes ORd 95% CI P
Had epilepsy attack
(in past year) 32.1 32.8 0.7 43.3 39.4 3.9 1.17 0.55–2.50 0.69
Had 1 attack a month
(in past year) 16.0 16.8 0.8 21.3 20.5 0.8 0.95 0.35–2.54 0.91
Other long-term health
problems 45.0 51.4 6.4 46.5 44.4 2.1 1.83 0.95–3.51 0.07
Injury as a result of epilepsy
attack (in past year) 12.8 10.8 2.0 20.0 14.8 5.2 0.92 0.41–2.04 0.84
Taking one type of
antiepileptic drug 67.5 66.7 0.8 65.2 61.6 3.6 1.74 0.61–4.95 0.30
Reported side effects from
drugs (in past month) 46.6 42.6 0.4 55.5 48.4 7.1 0.91 0.55–1.52 0.72
Feel very well controlled
by drugse 69.5 74.2 4.7 65.0 67.9 2.9 1.33 0.67–2.65 0.41
Feel stigmatized due
to epilepsy 36.3 36.3 0.0 31.6 35.0 3.4 0.90 0.45–1.80 0.76
Feel unhappy about their life
as a whole 46.8 46.8 0.0 49.6 46.6 3.0 1.12 0.60–2.10 0.73
a Patients who replied to the same questions in the baseline and follow-up surveys.
b Range of missing values: 0–46.
c Range of missing values: 0–38.
d Intervention vs. control patients, adjusting for baseline value of outcome variable in multiple logistic regression model.
e Excludes between 2–10 patients not currently on antiepileptic drugs.sion of an entire locality population, its inclusion of
a range of outcome and process measures, its empha-
sis on patient perspectives, and its control for baseline
differences.
The prominent effect of the service was the increased
prevalence of discussion about epilepsy, not only with
the epilepsy specialist nurse but also with general prac-
titioners (or other practice staff) and hospital doctors.
Ridsdale et al.5 reported increased levels of advice
recorded in medical notes as a result of an epilepsy
nurse intervention, but noted that this might partly
be due to the nurse’s better recording. Although the
epilepsy nurse worked both with the patients and prac-
tice staff, we propose that her effect was primarily
through her contact with patients, as intervention pa-
tients who saw the epilepsy nurse were more likely to
have discussed aspects of epilepsy with doctors than
the intervention patients who had not seen her. Contact
with the epilepsy nurse may have empowered these
patients to obtain more information from doctors. It
is possible that patients ascribed discussion with the
epilepsy nurse to discussion with doctors.
It is plausible that this increase in the prevalence
of discussion contributed to the improved satisfaction
with general practitioner care reported by interven-
tion patients. The level of information received has
been shown elsewhere to correlate with satisfaction
with health care7. Several studies suggest that improv-
ing patients’ satisfaction with health care increases
the likelihood of them following advice and treatment
regimes10.Statistical results should be interpreted in light of the
numerous hypotheses that were tested. Of 44 primary
outcome measures that were examined, eight showed
significant differences in changes in intervention pa-
tients, some of which may be due to chance alone.
However, chance is unlikely to explain the several sig-
nificant differences in communication outcomes; for
these the direction of effect was the same for all but
one.
Results suggest that a consultation with the epilepsy
nurse had an adverse effect on patients’ perception
of epilepsy affecting particular areas of everyday life.
It is possible that contact with an epilepsy specialist
nurse may underline the label of epilepsy and heighten
awareness of the restricting effects. This underlining
effect could evoke negative feelings similar to those
shown by patients who have been newly diagnosed with
epilepsy11 or other conditions12. Results also suggest
that the service had an adverse effect on compliance
with medication. This effect could be linked to an in-
creased awareness of the effect of epilepsy on their
lives, but is unlikely to be as a direct effect of see-
ing the nurse as there were no significant differences
in compliance between intervention patients who saw
the nurse and intervention patients who did not. Alter-
natively, intervention patients could now be better in-
formed about taking medication exactly as prescribed,
as this was part of the epilepsy nurse’s role, and thus
realize that they did not comply with their prescribed
regime. It has to be acknowledged, however, that this
single finding could be due to chance.
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Medicine 1978; 299: 741–744.Uptake of patient consultations with the epilepsy
nurse was lower than in other similar studies. Rids-
dale et al.5 reported an attendance rate of 83% and a
similar community epilepsy specialist nurse service in
Glasgow reported a response of 71% (N. Torrance—
personal communication). Unlike our study both Rids-
dale et al. and Torrance excluded certain patients, par-
ticularly those with other severe illnesses, severe psy-
chological illnesses and a low intelligence quotient.
This could account for their higher attendance rate.
Non-attenders in our study were more likely than at-
tenders to have reported having someone else fill in the
questionnaire on their behalf and having other long-
term health problems. To increase patients uptake of
the service the epilepsy nurse could target the less in-
dependent patients, as those without a current driver’s
licence and those who needed help when attending hos-
pital clinics were more likely to decline contact with
the epilepsy nurse.
The limitations of the study were systematic differ-
ences between intervention and control patients, due
to the non-randomized design, and the incomplete re-
sponse rate. In this study it was not appropriate to ran-
domize individual patients to either intervention or con-
trol groups, as part of the epilepsy specialist nurse’s
role was to educate the practice teams, thereby provid-
ing the service to the whole practice and patients. It
was also not acceptable to randomize practices as the
two general practitioners supervising the epilepsy nurse
needed to have her working in their practices from the
beginning. With only 14 units of randomization, bal-
anced groups would have been unlikely. Differences
between the intervention and control patients were sta-
tistically controlled for. This study demonstrates one
problem with a quasi-experimental design. As it was
necessary to use both baseline and follow-up data to ad-
just for baseline differences, despite response rates of
66% and 69% for each survey, the response rate for both
was 51%. There was slight contamination as 18 control
patients saw the epilepsy nurse, owing to the time lapse
in control patients returning the questionnaire and the
fact that latterly the epilepsy nurse started to work in the
control practices. This may have diluted the estimated
effects by contributing to improvements seen in con-
trol patients. Contamination would probably have been
greater if patients were randomized within practices.
This study provides evidence of an improvement,
after 1 year, in communication and satisfaction but
not health status resulting from the introduction of a
primary-care-based epilepsy service. A second follow-
up survey will be conducted after the second year. In ad-
dition qualitative interviews, aiming to obtain a deeper
understanding of patients’ views on the new service
and on current epilepsy care in general, are underway.
Future innovations in the provision of epilepsy care re-
quire thorough evaluation if they are to be funded. Apriority is for randomized controlled trials in various
settings which focus on a range of health outcomes over
longer periods.
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